A citation-based method for searching scientific literature

Megan C Best, Nicole Bartley, Chris Jacobs, Ilona Juraskova, David Goldstein, Ainsley J Newson, Jacqueline Savard, Bettina Meiser, Mandy Ballinger, Christine Napier, David Thomas, Barbara Biesecker, Phyllis Butow. BMC Cancer 2019
Times Cited: 15







List of co-cited articles
45 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
67
40

Next-generation sequencing in precision oncology: Patient understanding and expectations.
J Scott Roberts, Michele C Gornick, Lan Q Le, Natalie J Bartnik, Brian J Zikmund-Fisher, Arul M Chinnaiyan. Cancer Med 2019
22
40

The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
Megan Best, Ainsley J Newson, Bettina Meiser, Ilona Juraskova, David Goldstein, Kathy Tucker, Mandy L Ballinger, Dominique Hess, Timothy E Schlub, Barbara Biesecker,[...]. BMC Cancer 2018
9
55

Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Phillip S Blanchette, Anna Spreafico, Fiona A Miller, Kelvin Chan, Jessica Bytautas, Steve Kang, Philippe L Bedard, Andrea Eisen, Larissa Potanina, Jack Holland,[...]. Cancer 2014
59
33

Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers.
Subotheni Thavaneswaran, Lucille Sebastian, Mandy Ballinger, Megan Best, Dominique Hess, Chee K Lee, Katrin M Sjoquist, Wendy E Hague, Phyllis N Butow, R John Simes,[...]. Med J Aust 2018
20
26

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
193
26

Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.
R Liang, B Meiser, S Smith, N A Kasparian, C R Lewis, M Chin, G V Long, R Ward, A M Menzies, J N Harris-Wai,[...]. Eur J Cancer Care (Engl) 2017
14
28

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
83
26

Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein,[...]. Cancer 2016
34
26

Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
Jonathan M Marron, Steven G DuBois, Julia Glade Bender, AeRang Kim, Brian D Crompton, Stephanie C Meyer, Katherine A Janeway, Jennifer W Mack. Pediatr Blood Cancer 2016
29
26

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, Maria Schwaederle, Michael E Hahn, Casey B Williams, Pradip De, Amy Krie, David E Piccioni, Vincent A Miller,[...]. Nat Med 2019
226
20

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
68
20

Patient satisfaction with health care decisions: the satisfaction with decision scale.
M Holmes-Rovner, J Kroll, N Schmitt, D R Rovner, M L Breer, M L Rothert, G Padonu, G Talarczyk. Med Decis Making 1996
410
20

Skin cancer concerns and genetic risk information-seeking in primary care.
J Hay, K A Kaphingst, R Baser, Y Li, S Hensley-Alford, C M McBride. Public Health Genomics 2012
26
20

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes.
I Pellegrini, M Rapti, J-M Extra, A Petri-Cal, T Apostolidis, J-M Ferrero, T Bachelot, P Viens, C Julian-Reynier, F Bertucci. Eur J Cancer Care (Engl) 2012
22
20

Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review.
Tatiane Yanes, Amanda M Willis, Bettina Meiser, Katherine M Tucker, Megan Best. Eur J Hum Genet 2019
31
20

Tumor genome analysis includes germline genome: are we ready for surprises?
Daniel V T Catenacci, Andrea L Amico, Sarah M Nielsen, Daniel M Geynisman, Brittany Rambo, George B Carey, Cassandra Gulden, Jim Fackenthal, Robert D Marsh, Hedy L Kindler,[...]. Int J Cancer 2015
57
20

Personalised cancer medicine.
Sarah E Jackson, John D Chester. Int J Cancer 2015
161
20

Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative study.
Amy Rohrmoser, Theresia Pichler, Anne Letsch, C Benedikt Westphalen, Ulrich Keilholz, Volker Heinemann, Ute Goerling, Peter Herschbach. Psychooncology 2020
5
60

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
152
20

Revisiting Expectations in an Era of Precision Oncology.
Emily J Marchiano, Andrew C Birkeland, Paul L Swiecicki, Kayte Spector-Bagdady, Andrew G Shuman. Oncologist 2018
15
20

Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling.
Grace Davies, Phyllis Butow, Christine E Napier, Nicci Bartley, Ilona Juraskova, Bettina Meiser, Mandy L Ballinger, David M Thomas, Timothy E Schlub, Megan C Best. Transl Oncol 2020
4
75

Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.
Colin Me Halverson, Kristin E Clift, Jennifer B McCormick. J Community Genet 2016
31
20



How do research participants perceive "uncertainty" in genome sequencing?
Barbara B Biesecker, William Klein, Katie L Lewis, Tyler C Fisher, Martha Frances Wright, Leslie G Biesecker, Paul K Han. Genet Med 2014
50
13

Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Sharon L Manne, Daniel C Chung, David S Weinberg, Hetal S Vig, Zohra Catts, Melissa Klein Cabral, Kristen Shannon, Neal J Meropol. Cancer Epidemiol Biomarkers Prev 2007
19
13

Attitudes toward molecular testing for personalized cancer therapy.
Rafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, Susan K Peterson, Allison M Burton-Chase, Bryan M Fellman, Yisheng Li, Carolyn McKinney, Elmer V Bernstam, Funda Meric-Bernstam. Cancer 2015
40
13

Who gets genomic testing for breast cancer recurrence risk?
J T DeFrank, T Salz, K Reeder-Hayes, N T Brewer. Public Health Genomics 2013
24
13

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
59
13

Known unknowns: building an ethics of uncertainty into genomic medicine.
Ainsley J Newson, Samantha J Leonard, Alison Hall, Clara L Gaff. BMC Med Genomics 2016
53
13

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
13

The promise and challenges of next-generation genome sequencing for clinical care.
Katherine A Johansen Taber, Barry D Dickinson, Modena Wilson. JAMA Intern Med 2014
99
13

Oncologists' Use of Genomic Sequencing Data to Inform Clinical Management.
Michele C Gornick, Erin Cobain, Lan Q Le, Natalie Bartnik, Elena Stoffel, Scott Schuetze, Moshe Talpaz, Arul Chinnaiyan, J Scott Roberts. JCO Precis Oncol 2018
3
66

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
Jada G Hamilton, Elyse Shuk, Margaux C Genoff, Vivian M Rodríguez, Jennifer L Hay, Kenneth Offit, Mark E Robson. J Oncol Pract 2017
21
13

Cancer patients' views and understanding of genome sequencing: a qualitative study.
Nicci Bartley, Megan Best, Chris Jacobs, Ilona Juraskova, Ainsley J Newson, Jacqueline Savard, Bettina Meiser, Mandy L Ballinger, David M Thomas, Barbara Biesecker,[...]. J Med Genet 2020
10
20

Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer.
Phyllis Butow, Grace Davies, Christine E Napier, Timothy Schlub, Megan C Best, Nicole Bartley, Ilona Juraskova, Bettina Meiser, Mandy L Ballinger, Barbara Biesecker,[...]. JAMA Netw Open 2020
4
50

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
77
13

Precision oncology: separating the wheat from the chaff.
Jordi Remon, Rodrigo Dienstmann. ESMO Open 2018
20
13

Molecular profiling for precision cancer therapies.
Eoghan R Malone, Marc Oliva, Peter J B Sabatini, Tracy L Stockley, Lillian L Siu. Genome Med 2020
165
13

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
13

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
175
13

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
13

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
227
13

Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.
Melika Shirdarreh, Orly Aziza, Rossanna C Pezo, Katarzyna J Jerzak, Ellen Warner. Oncologist 2021
4
50


The case for desegregation.
Rhea W Boyd. Lancet 2019
20
6


Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing.
Christopher M Haggerty, Cynthia A James, Hugh Calkins, Crystal Tichnell, Joseph B Leader, Dustin N Hartzel, Christopher D Nevius, Sarah A Pendergrass, Thomas N Person, Marci Schwartz,[...]. Genet Med 2017
29
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.